What interstitial lung diseases are associated with Crohn's disease (Crohn's disease) and what is their typical age of onset, and how is the prognosis for these patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Crohn's disease is associated with several interstitial lung diseases (ILDs), primarily bronchiolitis obliterans, organizing pneumonia (BOOP), and granulomatous lung disease, with a typical age of onset between 25-45 years. These pulmonary manifestations typically develop after the intestinal disease has been established, though they can occasionally precede gastrointestinal symptoms 1. The prognosis for Crohn's-associated ILD is generally favorable when compared to idiopathic forms of these conditions.

Key Characteristics of Crohn's-Associated ILD

  • The most common ILDs associated with Crohn's disease are bronchiolitis obliterans, organizing pneumonia, and granulomatous lung disease 1.
  • These conditions often respond well to systemic corticosteroid therapy, which can lead to marked improvement in patients with ILD and necrotic nodules 1.
  • In some cases, respiratory problems may develop postcolectomy, highlighting the importance of considering the relationship between an unexplained cough and a “treated” nonpulmonary disorder 1.

Treatment and Management

  • Corticosteroid therapy, such as prednisone, is typically started at 0.5-1 mg/kg/day and gradually tapered over 3-6 months 1.
  • In steroid-resistant cases, immunomodulators like azathioprine or methotrexate may be added to the treatment regimen 1.
  • TNF-alpha inhibitors used to treat intestinal Crohn's can sometimes improve pulmonary manifestations as well 1.

Prognosis and Monitoring

  • Regular pulmonary function tests and chest imaging are essential for monitoring disease progression and preventing irreversible lung damage and fibrosis 1.
  • The mortality rate is low, with most patients achieving remission or stabilization with appropriate treatment, though some may experience recurrent episodes requiring repeated courses of therapy 1.

From the Research

Interstitial Lung Diseases Associated with Crohn's Disease

  • Crohn's disease is associated with several interstitial lung diseases, including:
    • Chronic bronchiolitis with nonnecrotizing granulomatous inflammation 2
    • Acute bronchiolitis associated with a neutrophil-rich bronchopneumonia with suppuration and vague granulomatous features 2
    • Cellular interstitial pneumonia with rare giant cells 2
    • Organizing pneumonia with focal granulomatous features 2, 3
    • Usual interstitial pneumonitis (UIP) 3
    • Langerhan's granulomatosis 3
    • Eosinophilic pneumonia 3
    • Bronchiolitis obliterans with organizing pneumonia 4

Typical Age of Onset

  • The age of onset for these interstitial lung diseases in patients with Crohn's disease can vary, with a mean age of 47 years reported in one study 2
  • The age range for patients with Crohn's disease and interstitial lung diseases can be quite broad, from 13 to 84 years 2

Prognosis

  • The prognosis for patients with Crohn's disease and interstitial lung diseases can be variable, with some patients experiencing significant morbidity 5
  • In one study, 16% of patients with interstitial lung disease had no respiratory symptoms at follow-up, while 55% had ongoing symptoms 5
  • Remission of both Crohn's disease and interstitial lung disease can be achieved in almost all patients with granulomatous lung disease 5
  • Steroids can be an effective treatment for many patients with interstitial lung diseases associated with Crohn's disease 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Noninfectious lung pathology in patients with Crohn's disease.

The American journal of surgical pathology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.